Future Medicinal Chemistry · 2020 · 20 citations · 21 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsEnzyme InhibitionLead Compound DesignLigand-based DesignMolecular DockingPotency OptimizationStructure-activity Relationship AnalysisAbsolute PotencyBiological Evaluation ReportHelicobacter Pylori InfectionMolecular Docking Of InhibitorsSurface Plasmon Resonance AnalysisUrease Inhibitors
Background: Identification of novel Ure inhibitors with high potency has received considerable attention. Methodology & results: Ure inhibition was determined using the indophenol method, the affinities to Ure were estimated via surface plasmon resonance. Seventeen new plus ten known N-monosubstituted thiosemicarbazides were synthesized and identified as novel Ure inhibitors. Out of these compounds, compound b5 shows excellent activity against both crude Ure from Helicobacter pylori (IC50 = 0.04 μM) and Ure in living cell (IC50 = 0.27 μM), with the potency being over 600-fold higher than clinical used drug acetohyroxamic acid, respectively. Surface plasmon resonance demonstrated the high affinity (Kd.#x00A0;= 6.32 nM) of b5 to Ure. Conclusion: This work provides a class of novel and promising Ure inhibitors.
21
Adil S. Aslam, Shams‐ul Mahmood, M. Shahid et al. · European Journal of Medicinal Chemistry · 2011 · 197 citations · Full text
George A. Jeffrey · Crystallography Reviews · 2003 · 156 citations
Zhu‐Ping Xiao, Zhiyun Peng, Jing-Jun Dong et al. · European Journal of Medicinal Chemistry · 2013 · 101 citations · Full text